Upregulation of miR-196b Confers a Poor Prognosis in Glioblastoma Patients via Inducing a Proliferative Phenotype
出版年份 2012 全文链接
标题
Upregulation of miR-196b Confers a Poor Prognosis in Glioblastoma Patients via Inducing a Proliferative Phenotype
作者
关键词
-
出版物
PLoS One
Volume 7, Issue 6, Pages e38096
出版商
Public Library of Science (PLoS)
发表日期
2012-06-20
DOI
10.1371/journal.pone.0038096
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China
- (2012) Wei Yan et al. PLoS One
- Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome
- (2011) Z. Zuo et al. BLOOD
- Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme
- (2011) Wei Yan et al. BRAIN RESEARCH
- MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients
- (2011) Radek Lakomy et al. CANCER SCIENCE
- A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis
- (2011) X. Tan et al. CLINICAL CANCER RESEARCH
- Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells
- (2011) Yingyi Wang et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma
- (2011) Sujaya Srinivasan et al. PLoS One
- MYC, PARP1, and Chemoresistance: BIN There, Done That?
- (2011) S. Ganesan Science Signaling
- Recent Advances in Therapy for Glioblastoma
- (2010) Jennifer Clarke et al. ARCHIVES OF NEUROLOGY
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- MiRNA-196 Is Upregulated in Glioblastoma But Not in Anaplastic Astrocytoma and Has Prognostic Significance
- (2010) Y. Guan et al. CLINICAL CANCER RESEARCH
- Epigenetic regulation of miR-196b expression in gastric cancer
- (2010) Kuo-Wang Tsai et al. GENES CHROMOSOMES & CANCER
- Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia
- (2010) D. Schotte et al. HAEMATOLOGICA
- The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells
- (2010) Ryutaro Aoki et al. JOURNAL OF HEPATOLOGY
- Accurate Molecular Classification of Renal Tumors Using MicroRNA Expression
- (2010) Eddie Fridman et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia
- (2010) Ebru Coskun et al. LEUKEMIA RESEARCH
- Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia
- (2010) Suman Bhatia et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Potential tumor suppressive function of miR-196b in B-cell lineage acute lymphoblastic leukemia
- (2010) Suman Bhatia et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Human MicroRNA Oncogenes and Tumor Suppressors Show Significantly Different Biological Patterns: From Functions to Targets
- (2010) Dong Wang et al. PLoS One
- Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization
- (2009) R. Popovic et al. BLOOD
- hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells
- (2008) Lei Shi et al. BRAIN RESEARCH
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
- (2008) Aaron J. Schetter et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- DBC1 is a negative regulator of SIRT1
- (2008) Ja-Eun Kim et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started